» Articles » PMID: 36531891

Nocturnal Dipping and Kidney Function Decline: Findings From the CKD in Children Study

Overview
Journal Kidney Int Rep
Publisher Elsevier
Specialty Nephrology
Date 2022 Dec 19
PMID 36531891
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Normally, blood pressure (BP) declines by at least 10% from daytime to nighttime. In adults, blunted nocturnal dipping has been associated with more rapid decline in kidney function. Nondipping is prevalent in children with chronic kidney disease (CKD). We sought to determine whether nondipping is associated with proteinuria and progression to kidney failure in children with CKD.

Methods: In the prospective CKD in children (CKiD) cohort, Cox proportional hazards models were used to evaluate the relationship between baseline nondipping and progression to kidney failure. Linear mixed effects models were used to evaluate the relationship between nondipping and changes in iohexol glomerular filtration rate (GFR) and urine protein-to-creatinine ratio (log-UPCR, mg/mg) over time.

Results: Among 620 participants, mean age was 11 (± 4) years, mean iohexol GFR was 52 (± 22) ml/min per 1.73 m, and 40% were nondippers at baseline. There were 169 kidney failure events during 2.9 years (median) of follow-up. Dipping status was not significantly associated with kidney failure overall (hazard ratio [HR] 1.08; 95% confidence interval [CI] 0.77, 1.51) or in those with (HR 1.21; 95% CI 0.53, 2.77) or without (HR 1.05; 95% CI 0.71, 1.55) glomerular disease. Dipping status did not modify the relationship between time and change in iohexol GFR or log (UPCR) from baseline (interaction values = 0.20 and 0.054, respectively).

Conclusion: Nondipping is not associated with end-stage kidney disease, GFR decline, or change in proteinuria within the CKiD cohort.

Citing Articles

Hypertension and Cardiovascular Risk Among Children with Chronic Kidney Disease.

Larkins N, Craig J Curr Hypertens Rep. 2024; 26(10):389-398.

PMID: 38806767 PMC: 11416368. DOI: 10.1007/s11906-024-01308-1.


Current perspective on circadian function of the kidney.

Benjamin J, Pollock D Am J Physiol Renal Physiol. 2023; 326(3):F438-F459.

PMID: 38134232 PMC: 11207578. DOI: 10.1152/ajprenal.00247.2023.


Effects of Nondipping Blood Pressure Changes: A Nephrologist Prospect.

Habas Sr E, Akbar R, Alfitori G, Farfar K, Habas E, Errayes N Cureus. 2023; 15(7):e42681.

PMID: 37649932 PMC: 10464654. DOI: 10.7759/cureus.42681.


Renal Biomarkers and Novel Therapies in Pediatric Nephrology: From Chronic Kidney Disease to Renal Transplantation.

Chirico V, Chimenz R J Clin Med. 2023; 12(11).

PMID: 37298005 PMC: 10253759. DOI: 10.3390/jcm12113810.


Role of hypertension in progression of pediatric CKD.

Mitsnefes M, Wuhl E Pediatr Nephrol. 2023; 38(11):3519-3528.

PMID: 36732375 DOI: 10.1007/s00467-023-05894-1.


References
1.
Bakhoum C, Vuong K, Carter C, Gabbai F, Ix J, Garimella P . Proteinuria and nocturnal blood pressure dipping in hypertensive children and adolescents. Pediatr Res. 2021; 90(4):876-881. PMC: 8313642. DOI: 10.1038/s41390-020-01315-3. View

2.
Wilson A, Flynn J . Blood pressure in children with chronic kidney disease: lessons learned from the Chronic Kidney Disease in Children Cohort Study. Pediatr Nephrol. 2019; 35(7):1203-1209. PMC: 7007321. DOI: 10.1007/s00467-019-04288-6. View

3.
Furth S, Cole S, Moxey-Mims M, Kaskel F, Mak R, Schwartz G . Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol. 2007; 1(5):1006-15. PMC: 3630231. DOI: 10.2215/CJN.01941205. View

4.
Bowles N, Thosar S, Herzig M, Shea S . Chronotherapy for Hypertension. Curr Hypertens Rep. 2018; 20(11):97. PMC: 6491046. DOI: 10.1007/s11906-018-0897-4. View

5.
Agarwal R, Light R . GFR, proteinuria and circadian blood pressure. Nephrol Dial Transplant. 2009; 24(8):2400-6. DOI: 10.1093/ndt/gfp074. View